Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

2018 End-of-Year Summary of FDA Advertising and Promotion Enforcement Activity

Alert

  • News and Insights
  • 2018 End of Year Summary of FDA Advertising and Promotion Enforcement Activity

This e-alert reviews trends emerging from warning letters and untitled letters concerning therapeutic product advertising and promotion issued in 2018 by the Office of Prescription Drug Promotion (OPDP) of the Center for Drug Evaluation and Research (CDER), the Advertising and Promotional Labeling Branch (APLB) in the Office of Compliance and Biologics Quality (OCBQ) of the Center for Biologics Evaluation and Research (CBER), and the Office of Compliance (OC) of the Center for Devices and Radiological Health (CDRH).

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Offices

Related Regions

Related News & Insights